Literature DB >> 30398075

Cortical astroglia undergo transcriptomic dysregulation in the G93A SOD1 ALS mouse model.

Sean J Miller1,2,3, Jenna C Glatzer1,2,3, Yi-Chun Hsieh1,3, Jeffrey D Rothstein1,2,3,4.   

Abstract

Astroglia are the most abundant glia cell in the central nervous system, playing essential roles in maintaining homeostasis. Key functions of astroglia include, but are not limited to, neurotransmitter recycling, ion buffering, immune modulation, neurotrophin secretion, neuronal synaptogenesis and elimination, and blood-brain barrier maintenance. In neurological diseases, it is well appreciated that astroglia play crucial roles in the disease pathogenesis. In amyotrophic lateral sclerosis (ALS), a motor neuron degenerative disease, astroglia in the spinal cord and cortex downregulate essential transporters, among other proteins, that exacerbate disease progression. Spinal cord astroglia undergo dramatic transcriptome dysregulation. However, in the cortex, it has not been well studied what effects glia, especially astroglia, have on upper motor neurons in the pathology of ALS. To begin to shed light on the involvement and dysregulation that astroglia undergo in ALS, we isolated pure grey-matter cortical astroglia and subjected them to microarray analysis. We uncovered a vast number of genes that show dysregulation at end-stage in the ALS mouse model, G93A SOD1. Many of these genes play essential roles in ion homeostasis and the Wnt-signaling pathway. Several of these dysregulated genes are common in ALS spinal cord astroglia, while many of them are unique. This database serves as an approach for understanding the significance of dysfunctional genes and pathways in cortical astroglia in the context of motor neuron disease, as well as determining regional astroglia heterogeneity, and providing insight into ALS pathogenesis.

Entities:  

Keywords:  ALS; SOD1; astroglia; neurodegeneration; transcriptome

Mesh:

Substances:

Year:  2018        PMID: 30398075      PMCID: PMC6444185          DOI: 10.1080/01677063.2018.1513508

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  81 in total

Review 1.  Heterogeneity of astrocytic form and function.

Authors:  Nancy Ann Oberheim; Steven A Goldman; Maiken Nedergaard
Journal:  Methods Mol Biol       Date:  2012

2.  p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration.

Authors:  C Turnquist; I Horikawa; E Foran; E O Major; B Vojtesek; D P Lane; X Lu; B T Harris; C C Harris
Journal:  Cell Death Differ       Date:  2016-04-22       Impact factor: 15.828

3.  Identification of diverse astrocyte populations and their malignant analogs.

Authors:  Chia-Ching John Lin; Kwanha Yu; Asante Hatcher; Teng-Wei Huang; Hyun Kyoung Lee; Jeffrey Carlson; Matthew C Weston; Fengju Chen; Yiqun Zhang; Wenyi Zhu; Carrie A Mohila; Nabil Ahmed; Akash J Patel; Benjamin R Arenkiel; Jeffrey L Noebels; Chad J Creighton; Benjamin Deneen
Journal:  Nat Neurosci       Date:  2017-02-06       Impact factor: 24.884

4.  Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1.

Authors:  Shayne A Bellingham; Louise A Coleman; Colin L Masters; James Camakaris; Andrew F Hill
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

5.  Overexpression of metal-responsive transcription factor (MTF-1) in Drosophila melanogaster ameliorates life-span reductions associated with oxidative stress and metal toxicity.

Authors:  Sepehr Bahadorani; Spencer Mukai; Dieter Egli; Arthur J Hilliker
Journal:  Neurobiol Aging       Date:  2008-09-04       Impact factor: 4.673

Review 6.  The role of the Wnt canonical signaling in neurodegenerative diseases.

Authors:  Rosaliana Libro; Placido Bramanti; Emanuela Mazzon
Journal:  Life Sci       Date:  2016-06-28       Impact factor: 5.037

Review 7.  Genome-wide association studies in Alzheimer's disease.

Authors:  Lars Bertram; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

Review 8.  Rodent Models of Amyotrophic Lateral Sclerosis.

Authors:  Thomas Philips; Jeffrey D Rothstein
Journal:  Curr Protoc Pharmacol       Date:  2015-06-01

Review 9.  How it all started: tau and protein phosphatase 2A.

Authors:  Chang Liu; Jürgen Götz
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Functional annotation of Alzheimer's disease associated loci revealed by GWASs.

Authors:  Zengpeng Han; Han Huang; Yue Gao; Qingyang Huang
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

View more
  4 in total

Review 1.  Glial Purinergic Signaling in Neurodegeneration.

Authors:  Marie J Pietrowski; Amr Ahmed Gabr; Stanislav Kozlov; David Blum; Annett Halle; Kevin Carvalho
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

2.  Novel Genetic Signatures Associated With Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Robert Logan; Juleah Dubel-Haag; Nicolas Schcolnicov; Sean J Miller
Journal:  Front Genet       Date:  2022-03-24       Impact factor: 4.599

3.  Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner.

Authors:  Michael MacLean; Judyta Juranek; Swetha Cuddapah; Raquel López-Díez; Henry H Ruiz; Jiyuan Hu; Laura Frye; Huilin Li; Paul F Gugger; Ann Marie Schmidt
Journal:  J Neuroinflammation       Date:  2021-06-15       Impact factor: 8.322

4.  Meta-analysis of mouse transcriptomic studies supports a context-dependent astrocyte reaction in acute CNS injury versus neurodegeneration.

Authors:  Sudeshna Das; Zhaozhi Li; Ayush Noori; Bradley T Hyman; Alberto Serrano-Pozo
Journal:  J Neuroinflammation       Date:  2020-07-31       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.